We have an exciting opportunity stemming from our recent receipt of a $1 million ORF (Ontario Research Fund) grant. This grant is a testament to the innovative work being conducted within our organization and the potential impact of our micelle nanoparticle technology.

In order to fully leverage this funding and maximize our research efforts, we are seeking partners interested in utilizing our technology for collaborative projects. By joining forces with collaborative organizations, we are able to match the government funding and propel these feasibility projects further with small initial investments.

 Our technology has applicability in a range of ocular conditions and other diseases affecting mucosal areas. These diseases affect a significant number of Ontarians, and their impacts will be even more pronounced with an aging population. We aim to improve the treatment for these patients by combining our delivery technology with our partners' therapeutic compounds. The patented micelle formulation will be modified to incorporate and release these compounds, while maintaining the mucoadhesive properties of our micelles.

 If your organization is interested in exploring a potential collaboration or would like more information about our technology and funding opportunities, please do not hesitate to reach out to us. We are eager to discuss potential partnerships and explore how we can work together to drive innovation and achieve shared goals.